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Varicocele is one of the most common causes of male infertility and spontaneous preg-
nancy rate after varicocelectomy is only about 30%. The most important seminal antio-
xidant is vitamin C but recent studies about the effects of vitamin C on spermatogenesis 
are controversial; therefore, we decided to evaluate its role after varicocelectomy. In a 
double blind randomized controlled clinical trial, 115 men with infertility and clinical 
varicocele with abnormal semen analyses were recruited. After surgery, the intervention 
group received vitamin C (250 mg bid) and the control group received placebo for three 
months. Mean sperm count, motility, and morphology index of two semen analyses 
(before and after surgery) were compared between the two groups. Univariate general 
linear model and stepwise linear regression were used in analysis. The mean age (±SD) 
of participants was 27.6±5.3 years. Vitamin C group had statistically significant better 
normal motility (20.8 vs. 12.6, P=0.041) and morphology (23.2 vs. 10.5, P<0.001) 
than placebo group. Considering the values prior to surgery as covariate, vitamin C was 
not effective on sperm count (P=0.091); but it improved sperm motility (P=0.016) and 
morphology (P<0.001) even after excluding the confounding effect of age (P=0.044 and 
P=0.001, respectively). Vitamin C was also an independent factor in predicting motility 
and normal morphology after surgery. Ascorbic acid can play a role as adjuvant treat-
ment after varicocelectomy in infertile men.
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The overall prevalence of infertility is up 
to 15% of couples and in half of the cases male 
factor is involved. Infertility has had an increasing 
trend during recent decades in Iran (1). In addi-
tion, the quality of semen in men has declined du-
ring the past few decades (2) and impaired sperm 
function has been considered as the most common 
cause of infertility (3).
Infertility is an important issue for couples 
with sometimes severe consequences. The treat-
ment of infertility requires a multi-faceted the-
rapeutic approach, consisting of improvements 
in environmental and occupational risk factors, 
nutritional imbalances, antioxidants, medical the-
rapies, surgeries, and assisted reproductive tech-
nology (ART).
Selvakumar E et al. established the effect 
of lipoic acid (an antioxidant like substance) in 
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improvement of semen quality and reducing the 
oxidative stress and DNA damage induced by 
cyclophosphamide in rats (4). Other antioxidants 
like vitamin C (ascorbic acid) and vitamin E have 
been proved to ameliorate the oxidative stress and 
sperm toxicity induced by endosulfan in rats (5). 
One before-after study evaluated the effects of vi-
tamins C and E (each one 500 mg/day) and de-
monstrated no efficacy of these antioxidants on 
DNA peroxidation in fertile and subfertile dogs; 
but, this controversial result could have been due 
to the very low sample size (6). The protective 
effects of ascorbic acid on p-dimethylaminoazo-
benzene induced genotoxicity and cytotoxicity 
have also been confirmed in mice (7).
Another study with a low sample size (ei-
ght healthy volunteers with azoospermia) illustra-
ted that administration of testosterone propionate 
over a four-week period did not change the level 
of ascorbic acid in human semen even after 12 
injections (8).
A recent review showed that vitamin C 
has controversial effects on sperm parameters and 
pregnancy rate in subfertile males with idiopathic 
oligoasthenoteratozoospermia (9).
Because the effect of vitamin C in sperma-
togenesis is still controversial and the proof for its 
clinical use challenging, we decided to evaluate its 
role as a supplement (as an antioxidant nutrient) 
after varicocele surgery (known as improving a 
definite cause of infertility). Previous population-
-based study on Iranian couples showed varicoce-
le as a main risk factor for infertility (1).
Varicocele is one of the most common cau-
ses of male infertility and although its surgical re-
pair results in improved spermatogenesis in 70% 
of patients, spontaneous pregnancy rate is only 
about 30% after varicocele repair without other 
treatments (10). Regarding the high prevalence of 
varicocele and suboptimal results of its surgical 
repair in improvement of pregnancy rates, addi-
tional treatment modalities are necessary. Recen-
tly, oxidative stress has been proposed to be an 
important factor in the pathophysiology of varico-
cele-induced infertility. The most important semi-
nal antioxidant is ascorbic acid (vitamin C) which 
comprises 65% (11, 12) of antioxidant capacity of 
semen and is currently used in-vitro to improve 
sperm quality in infertility clinics. Therefore, we 
decided to evaluate the effects of supplemental vi-
tamin C medical therapy after varicocelectomy for 
its probable improvement of infertility.
In this double-blind placebo controlled cli-
nical trial, we assessed the effects of adjuvant vi-
tamin C after varicocele surgery on sperm quality 
and quantity in infertile Iranian men.
MATERIALS AND METHODS
In this double blind randomized control-
led clinical trial, we recruited infertile males who 
had palpable varicocele (grades 2 and 3) from 
February 2010 to May 2011. In the presence of a 
palpable varicocele in physical examination and 
accompanying abnormalities in count, motility, 
or morphology of sperm in two separate semen 
analyses, they became candidates for surgery.
Other inclusion criteria were: age range 
between 18 and 50, weight between 50 and 100 
kilograms, and being married; the negative in-
clusion criteria were: absence of azoospermia, 
diabetes mellitus, hormonal disorders (according 
to medical history and clinical examination), 
tobacco smoking, opium or recreational drugs 
addiction, regular usage of vitamins or nutritio-
nal supplements, active or chronic genitourina-
ry infection (based on medical history, physical 
examination, semen and urine analysis), history 
of peptic ulcer, and previous reaction to or into-
lerance to vitamin C. Exclusion criteria were mis-
sed follow-up, incorrect usage of the capsules, 
demonstrating side effects due to vitamin C, and 
commencement of smoking or opium addiction 
during the follow-up period, and delayed com-
plications of varicocelectomy such as: hydrocele, 
recurrence of varicocele, and testicular atrophy.
In this study, infertility was defined as the 
inability to achieve a pregnancy after one year of 
unprotected regular intercourse. Normal semen 
sample was considered as defined by WHO (1999) 
(13): volume more than or equal to 2.0 mL, sperm 
count greater than or equal to 20 million per mL, 
motility (movement of the sperm) value greater 
than or equal to 50% with forward progression 
(grades “a+b”), or greater than or equal to 25% 
with rapid progression (grade “a”) within 60 mi-







nutes of ejaculation, morphology greater than 
or equal to 30% with normal forms, and white 
blood cell count less than 1 million per mL. All 
semen samples were obtained by masturbation in 
the lab and were analyzed in a reference labora-
tory (Sina Laboratory of Arak) by an experienced 
specialist in pathology and clinical laboratory 
medicine. Sperm counts were measured by the 
hemocytometer method using a Neubauer sperm 
counting chamber after immobilization of sper-
matozoa with neutral formalin. Sperm motility 
was calculated by scanning several fields under 
high-dry objective, until a total of at least 200 
spermatozoa were registered. Morphology was 
assessed by differential counts of morphologi-
cally normal and abnormal spermatozoa types 
on Pap-stained slides.
The surgical approach was open ingui-
nal method (Ivanissevich) which does not need 
special equipment and is still the most prevalent 
approach in Iran. All patients in both groups had 
varicocelectomy without image magnification. 
Our secondary complications were rare and they 
were excluded from the study and only those 
with clinically cured varicocele were selected for 
the final analysis. If there was any other unac-
counted factor from Ivanissevich method that 
could affect the results, since both groups had 
the same type of operation, it would be balanced 
in the two groups.
Randomization
After including 115 eligible patients that 
had surgery, we randomly allocated these patients 
into vitamin C (intervention) or placebo group 
according to simple randomization method using 
Excel 2010 software (Microsoft Corporation, Wa-
shington, USA) by “RANDBETWEEN(0;1000000)” 
function. The allocation sequence was produ-
ced by our statistician and was delivered to our 
pharmacist. Participants were enrolled by the 
two executive urologists who were unaware of 
the results of the allocation table. Then based on 
the numbers in the sequence being odd or even 
each new patient after varicocele surgery was as-
signed to intervention or placebo group by our 
pharmacist who supplied the drugs. The ratio of 
placebo to intervention group was 1.5. Therefore, 
46 cases were allocated to vitamin C and 69 ca-
ses to placebo group. Lost to follow-up patients 
were substituted with matching new cases. The 
intervention group received capsules containing 
250 mg of vitamin C (OSVAH Pharmaceutical Co. 
Tehran, Iran) in two daily doses, one in the mor-
ning and one in the evening. Controls received 
starch-filled capsules (Osveh Co., Tehran, Iran) as 
placebo. Both groups received capsules for three 
months after surgery.
Then, two separate semen analyses were 
obtained, each after 3 days of abstinence. Sam-
ples were collected inside the laboratory by mas-
turbation into sterile containers and allowed to 
liquefy at 37ºC for 30 min. Mean sperm count, 
motility, and morphology index of each of the 
two semen analyses (before and after surgery) 
were compared between two groups as our pri-
mary outcomes.Moreover, complications of sur-
gery, varicocele grade, age and weight were de-
termined.
Motility was defined as mean percent of 
good motility (type A plus type B) divided by all 
motility types (Type A+Type B+Type C+Type D). 
These types are defined as: Fast progressive (Type 
A), Slow progressive (Type B), Non-progressive 
(Type C), Immotile (Type D).
Statistical analysis
Descriptive indices like percent, mean, 
standard deviation (SD) were employed in this 
study. We also used chi-square for evaluating as-
sociation between categorical variables, repeated 
measure ANOVA for evaluating the simultaneous 
effect of both treatments (vitamin C or placebo) 
and time (before and after surgery). Student-t test 
was used for comparing quantitative variables in 
different groups. We used univariate general line-
ar model for comparing the status of quantitative 
indices of semen analysis after varicocelectomy 
considering baseline values as covariates (omit-
ting their confounding effect on post-surgery va-
lues) and stepwise linear regression for predicting 
post-surgery semen indices. P-value less than 0.05 
was considered statistically significant. All statis-
tical analyses were executed by SPSS 20 (SPSS 
Inc., Chicago, Illinois, USA).
ibju | Vitamin C and semen analysis after VariCoCeleCtomy
233
Ethics
We explained the aim and method of the 
study for the patients. All cases were aware of and 
accepted that they will receive vitamin C or place-
bo; however, they did not know which drug (inter-
vention or placebo) they would receive. All cases 
signed an informed written consent form before 
entering the study and they were informed that 
they could terminate their cooperation with use 
whenever they wanted without any consequences.
The trial is registered in Iranian Registry 
of Clinical Trials (IRCT) site (www.irct.ir), with the 
code number “IRCT201103042134N2”.
RESULTS
Mean age (±SD) of the participants was 
27.6±5.3 years. Five patients from the intervention 
group and eight patients from controls did not show-
-up for the follow-up visits and were substituted with 
matched new cases. We performed the intention to 
treat analysis in all parts of the study. The grades of 
varicocele were 2 and 3 in 9 (19.6%) and 37 (80.4%) 
of cases in vitamin C group and 10 (14.5%) and 59 
(85.5%) cases in placebo group, respectively. The gra-
de of varicocele was not statistically different betwe-
en vitamin C and placebo groups (P=0.473). Totally, 
in both groups, in 35 (30.4%) cases the sperm count 
worsened after the intervention. Also, in 22 (19.1%) 
and 14 (12.2%) cases the motility or normal morpho-
logy declined, respectively.
Basic characteristics of the two groups 
are presented in Table-1. As it shows, the inter-
vention group was younger; but semen analysis 
indices were not significantly different between 
the two groups.
Evaluating the simultaneous effect of 
treatment and time by repeated ANOVA showed 
that vitamin C group had statistically significan-
tly better status than the placebo group except 
for the sperm count which although was higher 
in the intervention group, the difference was 
not statistically significant (Table-2). Similarly, 
we compared the mean difference of values of 
different indices of semen analysis (for exam-
ple: mean of differences of sperm count before 
and after surgery in each intervention or placebo 
group) between the two groups using student t-
-test (Table-3). Again, motility and morphology, 
but not sperm count, were significantly better 
in vitamin C as compared to the placebo group.
Using univariate general linear model, 
we considered the values of before surgery as 
covariate and evaluated the effects of vitamin 
C in comparison with placebo on sperm indi-
ces. According to this analysis, vitamin C was 
not effective on sperm count (P=0.091), even 
after excluding the confounding effect of age 
(P=0.151). But, vitamin C was effective on sperm 
motility (P=0.016) and morphology (P<0.001) 
even after excluding the confounding effect of 
age (P=0.044 and P=0.001, respectively).
Table 1 - Basic characteristics of the intervention and placebo groups before treatment*
Group Sig.
Vitamin C Placebo
Age, year 26.3±4.9 28.5±5.5 0.025
Count, million/mL 42.5±28.4 37.5±28.1 0.362
Motility, % 33.8±15.5 32.4±14.3 0.618
Morphology, % 52.2±16.1 57±18.2 0.147
Oligozoospermia, % 30.4 26.1 0.610
Asthenozoospermia, % 89.1 91.3 0.698
Teratozoospermia, % 4.3 7.2 0.524
* = All variables refer to the condition of patients before surgery, values are presented as mean±SD







Stepwise linear regression showed that 
sperm count before intervention could significantly 
predict post-intervention sperm count (Table-4). 
The regression formula for count after surgery 
without vitamin C was:
Sperm count after surgery = (0.53 × sperm 
count before intervention) + 31.6
It shows that varicocelectomy by itself can 
increase the sperm count from 10 to 36.9 million/
mL irrespective of administration of vitamin C su-
pplementation.
Motility after surgery was also predictable 
by motility and morphology before intervention 
and vitamin C or placebo (Table-4). The regression 
formula was:
Sperm motility after surgery = (0.425 × mo-
tility before intervention) + (10.154 × D#) + (0.238 × 
morphology before intervention) + 17.6
# D=”1” if the intervention was vitamin C 
and “zero” if it was placebo
The value of normal morphology after sur-
gery was only dependent on morphology before 
intervention (Table-4). Its regression model was:
Sperm morphology after surgery = (0.404 
× morphology before intervention) + (9.758 × D#) 
+ 44.5
# D=”1” if the intervention was vitamin C 
and “zero” if it was placebo
 
Adjusted R-squares of these models were 
0.307, 0.170 and 0.248 for count, motility and 
morphology, respectively. It shows that the mo-
dels for predicting count and morphology had 
higher accuracy, respectively, irrespective of the 
number of independent variables included in the 
model. In each model, higher standardized beta 
Table 2 - Comparison of the results of the surgery between the intervention and placebo group*
Group Sig.
Vitamin C Placebo
Mean count, million/mL 58.4±24.3 48.7±27.8 0.328
Mean normal motility**, % 54.5±18.3 44.9±21.4 0.041
Mean normal morphology, % 75.3±13.1 67.5±16.4 <0.001
Normal count, % 95.7% 81.2% 0.025
Normal motility, % 67.4% 44.9% 0.066
Normal morphology, % 100.0% 98.6% 0.033
* = Values are presented as mean±SD; ** = Sum of (a+b) motility type




Counta, million/mL 15.9±25.3 11.1±26.2 0.328
Motilityb, % 20.8±21.3 12.6±20.5 0.041
Morphologyc, % 23.2±18.7 10.5±15.8 <0.001
* = all values are presented as mean±SD
a = (mean count after surgery - mean count before surgery); b = (mean motility after surgery - mean motility before surgery); c = (mean normal morphology after surgery - 
mean normal morphology before surgery)
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showed the more important predictors of the va-
lue of dependent variables.
DISCUSSION
Totally, in 30.4%, 19.1% and 12.2% of ca-
ses the sperm count, motility and normal morpho-
logy worsened after the intervention, respectively. 
Vitamin C was not effective on sperm count; but 
effective on sperm motility and morphology even 
after excluding the confounding effect of the age. 
Despite the statistically different age between vi-
tamin C and placebo groups, the age difference of 
2.2 years does not seem clinically important and 
based on the mean semen parameters before the 
surgery the two groups were comparable.
All our analyses in this study showed that 
vitamin C supplementation had significant posi-
tive effects on sperm motility and morphology; 
but not in sperm count in infertile young adult 
males with low quality sperm. It means that as-
corbic acid could positively affect qualitative and 
not quantitative characteristics of sperm analysis.
It is obvious that better sperm quantity or 
quality before surgery resulted in better situation af-
ter surgery for most patients (totally and not indivi-
dually because the model predicts the mean indices 
for all patients and not for each individual). Howe-
ver, the aim of our study was to answer whether 
vitamin C had an additive role for improvement of 
semen parameters after varicocelectomy, since our 
regression models showed vitamin C could increase 
post-operative motility and normal morphology but 
not sperm count. These findings confirmed the re-
sults of our univariate analyses.
One Egyptian study has shown that 
smoking significantly decreases seminal plasma 
ascorbic acid and it is also associated with re-
duced semen parameters which can worsen male 
fertilization potential (14). Subsequently, we ex-
cluded smokers and drug addicts from our study 
to restrict the confounding effect of smoking and 
related habits.
Colagar AH and Marzony ET showed that 
fertile smoker men have lower concentrations of 
seminal ascorbic acid than fertile non-smokers. 
This study also illustrated that infertile smokers 
have lower vitamin C level than fertile smoker 
men (12).
One observational study on healthy non-
-smoking American volunteers established that 
higher intake of antioxidants consisting of vita-
min C by normal diet or supplement usage is asso-
ciated with higher sperm count and motility (15). 
Our study was a randomized controlled clinical 
trial (RCT) and included cases after varicocele sur-
gery, thus these differences make these two studies 
non-comparable. However, both results support 
the same issue which is effectiveness of vitamin C 
on fertility indices of the semen.
Table 4 – Stepwise linear regression model of post-surgical indices of semen analysis.
Dependent 
variable
Independent variable Unstandardized Coefficients Standardized 
Beta
Sig. Model
Beta SE of Beta R-square Sig.
Count Sperm count before 
intervention
0.53 0.074 0.56 <0.001 0.31 <0.001
Motility Motility before 
intervention
0.425 0.120 0.303 0.001 0.192 <0.001
Giving vitamin C 10.154 3.630 0.241 0.006
Normal morphology 
before intervention
0.238 0.102 0.201 0.022
Morphology Normal morphology 
before intervention
0.404 0.073 0.452 <0.001 0.261 <0.001
Giving vitamin C 9.758 2.604 0.307 <0.001







The evaluation of the effects of different 
dosages of vitamin C on infertility needs more 
sophisticated studies; however, one study has 
shown that an increase in vitamin C dosage from 
200 to 1000 mg per day significantly improved 
sperm quality (16).
Before surgery, most of our cases had poor 
sperm motility but over two-thirds had normal 
sperm counts. Thus, the improvement in semen in-
dices with vitamin C cannot be generalize to all pa-
tients and more studies in different populations with 
different pre-surgery patterns of sperm analysis es-
pecially in those with more severe oligozoospermia, 
are needed.
Varicocelectomy is not a definite treatment 
for infertility in cases who have varicocele (17) and 
in some of our cases sperm analysis even worsened 
after surgery. Since none of our patients had tes-
tis atrophy, vascular damage during surgery could 
not be a culprit and progressive degeneration of 
spermatogenesis as the natural course of varicocele 
should have been the cause.
One study on 30 subfertile men showed that 
varicocelectomy decreased oxidative damage in 
sperm DNA and improved the quality of sperm (18). 
Another study on 13 infertile patients demonstrated 
similar results to our study; but, due to small sample 
size their findings were not statistically significant 
(19).
Pesticides produce sperm toxicity and one 
animal study on mice showed that vitamin C can 
prevent these effects. This study proved that higher 
doses of vitamin C resulted in more significant ame-
lioration of sperm count and morphology after ad-
ministration of pesticides (20).
Audet I et al. demonstrated that water solu-
ble vitamins improved semen production and motile 
sperm counts in boars (21).
Another study on rainbow trouts showed that 
sperm concentration and motility (fertility) decreases 
in fishes with ascorbic acid deficiency and vitamin C 
is important for male fish reproduction (22).
On the other hand, Donoghue AM and Do-
noghue DJ demonstrated that vitamin C had no 
effect on sperm viability, membrane integrity, or 
sperm motility index in turkeys at any concentra-
tion or time period tested (23). Moreover, in one 
RCT on 31 infertile men with asthenozoospermia, 
administration of high-dose oral vitamin C (1000 
mg) and E (800 mg) for 56 days did not show any 
effect on semen parameters or pregnancies during 
the treatment period (24). It should be noted that 
these patients’ infertility was due to causes other 
than varicocele and the only treatment they recei-
ved were vitamin supplements; therefore, this study 
could not be compared to ours.
A recent study has shown that vitamin C 
partially reduced semen oxidative stress level and 
number of abnormal sperms; but, did not improve 
sperm motility in hyperglycemic rats (25).
One study in Spain illustrated that 1 g vita-
min C and 1 g vitamin E daily for two months in 38 
cases with elevated percentage of DNA-fragmented 
spermatozoa decreased fragmentation in 76% of ca-
ses. This study showed no effect on fertilization and 
cleavage rates or on embryo morphology after ICSI; 
however, clinical pregnancy and implantation rates 
improved (26).
At present, a large proportion of the Iranian 
population ingests insufficient amounts of antioxi-
dants like vitamin C. According to a recent study, 
vitamin C intake was lower than the recommended 
daily allowance (RDA) in 28% of urban men and 
55% of men living in rural areas of Iran. In 6% of 
urban men and 13% of rural men, the daily intake 
of vitamin C was lower than the lowest threshold 
intake (LTI) (27).
In 2010, the mean intake of fruit and vege-
table servings per day was 1.74±1.16 in 102 elderly 
Iranian men (28) which is far from the minimum 
recommended five servings of fruits and vegetables 
per day in 2002 (Centers for Disease Control and 
Prevention (CDC)) (29). Our findings suggest that a 
healthy diet with sufficient supplements might be 
an inexpensive and safe way to improve semen 
quality and fertility.
There have not been many studies concer-
ning the role of vitamin C in the treatment of male 
infertility and still controversies exist due to diffe-
rent basic characteristics of the study samples, cau-
se of infertility, small sample sizes, comorbidities, 
hormonal status, and other co-variables that poten-
tially influence the results in such clinical studies.
Since vitamin C is a safe and cheap supple-
ment with possible therapeutic effects in some ca-
ses of male infertility, further studies are necessary.
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Limitations
We did not assess the levels of ascorbic 
acid in serum or semen of the patients and de-
monstration of the relation of seminal vitamin C 
levels with improvement in sperm indices could 
have supported our findings.
We used conventional semen analysis 
which is not an accurate predictor of fertility as 
Purvis K. and Christiansen E have shown that 
many cases with below normal values of sperm 
are able to impregnate their partners (30). The 
best outcome for evaluation of improvement in 
infertility is pregnancy rate which needs long 
term follow-ups.
Strengths
Because of variations between multiple 
samples from the same person, we obtained two 
separate samples from each case and mean va-
lues of all indices were used in all analyzes. Our 
inclusion and exclusion criteria have limited 
the reproducibility of our results to nonsmoker 
young infertile males with clinical varicocele, 
while it increased the accuracy of the study by 
removing many confounders which might have 
distorted the results.
Thirty six percent of couples with low 
sperm counts are able to achieve natural con-
ception without any therapy. Thus, studies about 
the effectiveness of different therapies in male 
infertility without control groups have doubtful 
results (17). As a result, we included placebo as 
control group in our study.
Most of the mentioned studies concer-
ning the effects of vitamin C on male infertility 
in human subjects had small sample sizes. Ho-
wever, our larger sample size helped in obtai-
ning statistically significant results.
CONCLUSIONS
Despite the controversies about the 
effects of ascorbic acid on spermatogenesis, 
most studies suggest a positive effect. The pre-
sent study showed that vitamin C can play a 
role as adjuvant treatment after varicocelec-
tomy in infertile men specifically on quality and 
not quantity of sperm.
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